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Various cDNAs coding for part or all of human pre-pro lactase-phlorizin hydrolase (pre-proLPH) were transfected into COS cells and the 
subcellular location of the lactase-related proteins assessed. Only the complete proLPH reached the plasma membrane. LPH without the pro 
sequence, and a construct containing the pro sequence and the lactase domain of mature LPH, accumulated intracellularly; the pro sequence with 
no mature domain was secreted. We conclude that the pro sequence is important for LPH to be transported to the cell surface. 
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1. INTRODUCTION 
The primary translation products of most secretory, 
lysosomal and some plasma membrane proteins un- 
dergo, in addition to the action of signal protease (if the 
case), more or less extensive proteolytic processing. The 
biological function of the pro sequences thereby split 
away is often not known. 
The case of the lactase (LPH, lactase-phlorizin hydro- 
lase, EC 3.2.1. 23-26) of the intestinal brush border 
membrane is rather special. In the sequence of its pri- 
mary translation product (pre-proLPH, 1,927 amino 
acid residues long in human [l]), one finds at the NH2- 
terminus a typical signal sequence, which, as predicted 
[l], is split after pos. 19 [2]; the COOH-terminal end 
encompasses the hydrophobic transmembrane anchor 
and a hydrophilic cytosolic segment. In between, four 
homologous regions (I to IV) can be recognized; only 
the two distal ones appear in mature brush border LPH 
and have lactase and phlorizin hydrolase activity, re- 
spectively [3]. The amino acid sequence between pos. 20 
and 868 (the NH,-terminus of mature brush border 
LPH is pos. 869) does not appear in the brush borders 
(save for the proLPH escaping intracellular proteolytic 
processing; see below). Mature LPH therefore com- 
prises only some 60% of the sequence of its primary 
translation product. Lactase is perhaps the only (or one 
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Various segments of LPH cDNA, derived from plasmids pHlac61 
and pHlac5 [l] were cloned into the vector pSCT-Gal-X556 [S] down- 
stream of the cytomegalovirus promoter, between Hind111 and PvuII 
sites: (i) For pSCT-pre-proLPH (Fig. la) HindIIYSucI (01697) from 
pHlac61 and SucYEco RI blunted (697/6286) from pHlac5 were used. 
of the very few) intrinsic membrane protein which 
undergoes such extensive proteolytic processing. Also, 
it is rare, if not unique, that the ‘discarded’ pro sequence 
should be homologous to the mature protein - as men- 
tioned above, only regions III and IV appear in mature 
LPH; the homologous regions I and II belong to the pro 
sequence, and do not reach the plasma membrane. 
Does this long pro sequence have any function? An 
obvious possibility would be that region I and/or II has 
an enzymatic activity similar to that of the homologous 
regions III and IV in mature LPH. However, unproc- 
essed proLPH expressed in COS cells has the same 
molar specific lactase and phlorizin hydrolase activity 
as mature LPH [4]; also, a key amino acid residue of the 
active sites of lactase and phlorizin hydrolase (a Glu) is 
missing in the corresponding positions of regions I and 
II [3]. It is therefore most unlikely that regions I and II, 
i.e. the pro sequence, have glycosidase activity. 
In the present investigation we have explored the pos- 
sibility that the pro sequence of proLPH may be neces- 
sary for LPH to reach the plasma membrane. We have 
expressed constructs encompassing various parts of 
human pre-proLPH in COS cells, and found that the 
pro sequence is in fact required for the protein to reach 
the plasma membrane. 
2. MATERIALS AND METHODS 
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(ii) For pSCT-pre-III-IV (Fig. lb), first HindIII/AvuII (blunted) (O/ 
128) from pHlac61 and XFWIINCOI (2547/3052) were subcloned into 
HindIII and NcoI-cleaved pSCT-Gal-X556; the HindIIVNcoI frag- 
ment isolated from this plasmid and NcoUEcoRI blunted (305~6286) 
from pHlac5 were then cloned into pSCT-Gal-X556 as before. (iii) 
pSCT-pre-pro-111 (Fig. lc) was constructed with HindIIYSacI from 
pHlac61 and SucYClaI blunted (697/4441) from pHlac5. (iv) pSCT- 
pre-pro (Fig. Id) contains HindIIIISacI from pHlac61 and SucIIPvuII 
(697/2885). 
2.2. ~ransfe~t~on of COS eetis 
COS-7 cells were cultured in Dulbecco’s modified Eagles medium 
(Gibco) with 10% fetal calf serum, 50 U/ml penicillin, and 50 fig/ml 
streptomycin (= complete medium). For transfection, cells in &well 
plastic dishes at 20-50% confluence were washed twice with 1 ml 
Opti-MEM (Gibco), and treated with 1 ml Opti-MEM containing 1.5 
fig plasmid DNA plus 6 ~1 Lipofectin (Gibco). After 6 h at 37°C 1 ml 
complete medium was added and cells were grown for another 48-72 
h. Cells were labelled by incubating in methionine-free complete me- 
dium (with dialyzed fetal calf serum) for 0.5-l h followed by 1 ml of 
the same medium with 35 to 50 yCi [‘5S]methionine for 3-5 h; in some 
cases a ‘chase’ of 18 h was performed in complete medium supple- 
mented with 2.5 mM methionine. 
2.2. Antlers against he pro region of hu~n proLPH 
A segment of cloned cDNA [1] coding for amino acids 267-361 of 
human proLPH was amplified by PCR using primers furnished with 
a BumHI site for the plus strand and an &oRI site for the minus 
strand, and cloned into the pGEX-2T expression vector (Pharmacia) 
so that the protein was expressed as a fusion with the glutathione-B 
transferase of Schistosoma j ponicum. Fusion protein produced in E. 
co& pmifi~ by SDS-PAGE and el~roelution, was used for immuni- 
zation of rabbits (125 @g for the first immunization, with Freund’s 
complete adjuvant, 63 pg with incomplete adjuvant for each of 2 
subsequent injections). 
essed (at least not completely), as has been previously 
reported [4]. Similarly, #CT-pre-pro-III, coding for the 
pre-pro region plus region III (Fig. lb), could be de- 
tected with both antibodies (Fig. 2, lanes 4 and 6). The 
observed molecular weight of 180,000 is larger than the 
165,000 expected for the polypeptide chain alone, sug 
gesting that the protein is glycosylated and that pro- 
teolytic processing is minimal. With plasmid pSCT-pre- 
III-IV, coding for the signal sequence plus mature LPH 
(Fig. lc), a polypeptide with apparent molecular weight 
of 95,000 was seen (Fig. 2, lane 3), considerably smaller 
than the 121,000 predicted for the polypeptide chain 
alone. The pre-pro segment alone (Fig. Id), without the 
mature LPH domains, was as expected not bound by 
the monoclonal antibody against mature LPH (Fig. 2, 
lane 2), but was readily detectable with the antiserum 
against the pro region (lane 6). After a ‘chase’ of 18 h, 
the product could be recovered from the medium (lane 
8), showing that it is secreted. None of the other LPH- 
related poIypeptides was found in the medium {not 
shown). 
3.2. Localization of LPH-related proteins 
COS-7 cells were transfected with pSCT-pre-pro- 
LPH, pSCT-pre-III-IV, and pSCT-pre-pro-III. After 48 
h the cells were fixed and either pe~eabiliz~ with 
Triton X-100 (+Tx) or not ~~eabilized (-TX) (see 
Fig. 3), and indirect immunofluorescence was used to 
assess whether the LPH derivatives reached the cell sur- 
face. 
2.3. Immunoisolution a d immunofluorescence 
Detergent extracts were prepared as described previously for mu- 
cosal explants [6], except that the protease inhibitor mix contained 5 
mM EDTA, lSO,@ml PMSF, 2/@/m] pepstatin A, 2,f@ml aprotinin, 
10 &ml leupeptin, 40 @ml benzamidine, 2&ml bestatin, 3 @g/ml 
E-64, and 400 @ml o-phenanthroline. LPH and its derivatives were 
isolated [6] with the antiserum described above or with a monoclonal 
antibody against mature LPH [7] and the products were separated on 
6% acrylamide gels according to Laemmli [8] and detected by fluoro- 
graphy. 
For immunofluorescen~, transfected COS-7 cells grown on co- 
verslips were fixed for 30 min with 3% paraformaldehyde, treated for 
15 min with 0.1 M glycine in PBS, and permeabilized or not for 5 min 
with 0.25% Triton X-100 in PBS. LPH or its derivatives were detected 
with the monoclonal anti-human LPH antibody and FITC-conjugated 
goat anti-mouse secondary antibody (l:lOO, Tago AG) . 
The results (Fig. 3) can be summarized as follows: (i) 
the expression of pre-proLPH leads to the appearance 
of immunoreactive lactase in the plasma membrane -
presumably proLPH 141; (ii) transfection with pSCT- 
pre-III-IV, coding for the signal sequence and all of 
mature LPH but essentially no pro sequence, leads to 
the intracellular expression of a lactase-related polypep- 
tide which is not transferred to the plasma membrane. 
Cotransfection of pSCT-pre-pro with pSCT-pre-III-IV 
did not ‘rescue’ transport to the plasma membrane (not 
shown). (iii) The expression of pre-pro-111 (i.e. of a con- 
struct encompassing the signal sequence plus regions I, 
II and III) leads again to the solely intracelltdar expres- 
sion of lactase-related poIy~ptide. 
3. RESULTS 
3.1. Production of LPH derivatives in COS cells 
4. DISCUSSION 
The complete pre-proLPH cDNA was cloned down- Of the various LPH derivatives tested, only the com- 
stream from the cytomegalovirus promoter in the ex- plete proLPH is transferred to the plasma membrane. 
pression vector pSCT-Gal-X556 (Fig. 1 A) [5]. When The (hydrophilic) pro sequence is secreted into the me- 
this construct was introduced into COS cells and the dium, whereas pro sequence-region III remains in the 
cells labelled with [35S]methionine for 3.5 h beginning 60 cells. Whereas the secretion of pro sequence into the 
h after infection, a protein with apparent molecular medium comes as no surprise, it is not clear why the 
weight 215,000 could be immunoisolated with either equally hydrophilic pro sequence-region III is not also 
monoclonal antibody against mature LPH (Fig. 2, lane secreted. Mature, membrane-anchored LPH, presuma- 
1) or with antiserum against a segment of the pro region bly arising from the construct pre-III-IV, does not reach 
(lane 5). Thus proLPH was not proteolytically proc- the cell surface. 
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Fig. I. Human pre-proLPH and derivatives expressed in COS cells. In (a), various domains of the complete polypeptide are labelled, and the 
horizontal arrows at the bottom indicate four homologous regions within the sequence. In pre-III-IV (b) the pro region is almost entirely deleted. 
In pre-pro-111 (c) the polypeptide is truncated at position 1,477, near the beginning of region IV, and in pre-pro (d) the sequence nds at position 
959, deleting almost all of the mature LPH sequence. 
Although we do not know in which intracellular com- (i) The pro region in proLPH may carry a target, or 
partment or compartments the pre-III-IV or pre-pro-III allow a target to be exposed, that is required for 
constructs are retained or transferred to (lysosomes?), proLPH to be transferred to the TGN and later com- 
it is clear that the pro sequence is needed for LPH to partments (in explants of small-intestine the processing 
reach the plasma membrane. At least the following of proLPH to LPH takes place in the TGN [6]). 
mechanisms can be envisaged, alone or in combination: (ii) The pro region may protect the mature LPH do- 
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Fig. 2. Immunoisolation of LPH-related polypeptides produced in transiently transfacted COS cells. Plasmids coding for the polypeptides hown 
in Fig. 1 were introduced into COS cells and the cultures labelled with [“Slmethionine beginning at 60 h after transfection. LPH derivatives were 
immunoisolated either from cell homogenates prepared immediately after labelling (A and B) or from the culture medium after an 18 h ‘chase’ 
(C). Either monoclonal antibody against mature LPH (A) or antiserum against he pro region (B,C) was used. Lanes 1and 5, pre-proLPH; lanes 
2, 7, and 8, pre-pro; lane 3, pre-III-IV; lanes 4 and 6, pre-pro-III; lane 9, untransfected COS celts. 
main from proteolytic degradation The two constructs 
that do not reach the cell surface are those occurring as 
polypeptides with incomplete mature LPH domains - 
pm-pro-III by design, and pre-III-IV through degrada- 
tion. If degradation of pre-III-IV is the primary event, 
and not simply a consequence of the polypeptide not 
being transported properly, then an important function 
of the pro sequence may be to stabilize the mature LPH 
against protease action, This could occur, for example, 
by hindering the access of protease to a sensitive bond 
or by inducing a glycosylation event with a similar ef- 
fect. The pro sequence might be required only tran- 
siently for initiation of proper folding and stabilization 
of mature LPH. Such a ‘chaperone-like’ role has been 
suggested for the pro sequence of subtilisin [9?10] and 
of Kex2p (D. Germain, D.Y. Thomas, and G. Boileau, 
in preparation). 
(iii) The pro sequence in proLPH may be needed for 
it to proceed past the ER, e.g. by forming an intramol- 
ecular ‘quasi homodimer’. It is a well established notion 
that most proteins synthesized in the ER have to form 
homo- or heterooligomers in order to leave this com- 
partment 11 1,121. Proteins easily form homooligomers, 
and theoretical considerations uggest particularly ho- 
modimers may be favored [13,14] (Repeated experi- 
ments in our Department reproducibly show that a right 
hand can shake another right hand more easily than a 
left hand). Clearly, the ~~~$~olec~lar formation of 
‘quasi-(homo)oligomers’ (i.e. the interaction between 
two or more similar or identical domains belonging to 
a single polypeptide chain) is kinetically more favorable 
than the formation of complexes of separate polypep- 
tide chains. We suggest that these ~~~r~ole~~ar ‘quasi- 
~homo)oligomers~ do not have to further interact with 
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like or unlike polypeptides to proceed past the ER. It 
is thus possible that this is the biological raison d’etre 
of the pro region in proLPH, and explains why many 
of the brush border hydrolases are synthesized as dou- 
ble, or even four-fold, proteins. These include, in addi- 
tion to proLPH, sucrase-isomaltase [ 15,161, angiotensin 
converting enzyme [ 17,181, the AdRab-B esterase/phos- 
pholipase [ 19& and probably glucoamylase [l&20,2 13. 
There is some experimental evidence that at least 
some of these double proteins do not form quaternary 
homo- or heterooligomers in the ER or the Golgi, 
namely for proLPH [223, for pro-sucrase-isomaltase (in 
Caco-2 cells, [23]), and angiotensin converting enzyme 
[18]. In contrast, ‘simple’ proteins, such as aminopepti- 
dase N (in intestinal explants [22]) or dipeptidyl pepti- 
dase IV (in ho-2 cells [23J) seem to form hom~imers 
at an early stage of their biosynthesis. However, even 
‘double” proteins such as LPH [22], sucrase-isomaltase 
[24] and glucoamylase [25] do form homodimers at a 
later stage, shortly before or after they reach the brush 
border membrane. This may make them less susceptible 
to degradation by pancreatic proteases. 
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NOTE ADDED IN PROOF 
Very recently Liang et al. (1993) have shown that a 
genetically engineered ‘double’ protein does form intra- 
molecular homodimers substantially faster than identi- 
cal, but separated, subunits do. (Liang, H., Sandberg, 
W.S. and Terwilliger, T.C. (1993) Proc. Natl. Acad. Sci. 
USA 90, 701&7014.) 
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